# Isomorphic Labs raises $5 billion Series C co-led by Greenoaks and Sequoia

> Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C round on Nov. 17.

- Publisher: JARRUS (@jarrus.tech), thejarrus.com
- Story date: Nov. 17, 2026 (2026-11-17)
- Published: 2026-11-18
- Tags: Google, Funding and deals, Pricing and access
- URL: https://thejarrus.com/en/news/isomorphic-labs-series-c/

Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C round on Nov. 17. Greenoaks and Sequoia Capital co-led the round, Andreessen Horowitz joined as a new investor, and Alphabet continued to invest. All existing investors took part, including Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund. The company said the money will go toward its drug design engine IsoDDE and the infrastructure to take its candidates into clinical trials. It reported positive preclinical results in oncology and immunology. The valuation was not disclosed. The previous round was a $2.1 billion Series B led by Thrive Capital in May 2026.

## Sources

1. [Isomorphic Labs: Isomorphic Labs announces Series C investment round, Nov. 17, 2026](https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-c-investment-round)
2. [Isomorphic Labs: Isomorphic Labs announces $5 Billion Series C funding (basın bülteni, PDF), Nov. 17, 2026](https://storage.googleapis.com/isomorphiclabs-website-public-artifacts/ISOMORPHIC_LABS_FUNDING_17-11-26.pdf)
3. [TechCrunch: Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials, Nov. 17, 2026](https://techcrunch.com/2026/11/17/isomorphic-labs-raises-5b-as-it-looks-to-take-drug-candidates-to-clinical-trials/)
4. [Isomorphic Labs: Isomorphic Labs announces Series B investment round, May 12, 2026](https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round)

Report an error: corrections@thejarrus.com
